Relationship of adipokines (adiponectin, resistin and RBP4) with metabolic syndrome components in pubertal obese children

Biomarkers in Medicine

Volumn 7, Issue 3, 2013, Pages 423-428

  Boyraz, Mehmet ^a   Cekmez, Ferhat ^b   Karaoǧlu, Abdulbaki ^b   Cinaz, Peyami ^c   Durak, Mustafa ^d   Bideci, Aysun ^c  

^a Sisli Etfal Education Hospital   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^d MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

adiponectin; metabolic syndrome; RBP4; resistin

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHILD; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HOMEOSTATIC MODEL ASSESSMENT INSULIN RESISTANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; METABOLIC SYNDROME X; OBESITY; PATIENT ASSESSMENT; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PUBERTY; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADOLESCENT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHILD; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; OBESITY; PUBERTY; RESISTIN; RETINOL-BINDING PROTEINS, PLASMA; TURKEY;

EID: 84878685792     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.13.14     Document Type: Article

References (31)

1. Ogden CL, Carroll MD, Curtin LR, Mcdowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295(13), 1549-1555 (2006).
2. Kranz S, Mahood LJ, Wagstaff DA. Diagnostic criteria patterns of U.S. children with metabolic syndrome: NHANES 1999-2002. Nutr. J. 6, 38 (2007).
3. Lebensztejn DM, Wojtkowska M, Skiba E, Werpachowska I, Tobolczyk J, Kaczmarski M. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease. Adv. Med. Sci. 54(2), 177-182 (2009).
4. Chrzanowska J, Zubkiewicz-Kucharska A, Noczynska A. Adipocytokines concentration and metabolic parameters in obese children. Pediatr. Endocrinol. Diabetes Metab. 17(3), 145-151 (2011).
5. Deboer MD. Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions. Nutrition 29(2), 379-386 (2013).
6. Okamoto Y, Arita Y, Nishida M et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm. Metab. Res. 32(2), 47-50 (2000).
7. Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes. Nature 409(6818), 307-312 (2001).
8. Jia W, Wu H, Bao Y et al. Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J. Clin. Endocrinol. Metab. 92(8), 3224-3229 (2007).
9. Kloting N, Graham TE, Berndt J et al. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab. 6(1), 79-87 (2007).
10. Lee PA, Houk CA. Puberty and its disorders. In: Pediatric Endocrinology (5th Edition). Informa Healthcare, NY, USA, 273-304 (2007)
11. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15(7), 539-553 (1998).
12. Hatipoglu N, Ozturk A, Mazicioglu MM, Kurtoglu S, Seyhan S, Lokoglu F. Waist circumference percentiles for 7- to 17-year-old Turkish children and adolescents. Eur. J. Pediatr. 167(4), 383-389 (2008).
13. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2 Suppl. 4th Report), S555-S576 (2004).
14. Rosenbloom AL. Diabetes diagnosis in the child and adolescent: diagnosis and classification. In: Pediatric Endocrinology (5th Edition). Informa Healthcare, NY, USA, 58 (2007).
15. Valerio G, Licenziati MR, Iannuzzi A et al. Insulin resistance and impaired glucose tolerance in obese children and adolescents from southern Italy. Nutr. Metab. Cardiovasc. Dis. 16(4), 279-284 (2006).
16. Makni E, Moalla W, Lac G et al. The Homeostasis Model Assessment-adiponectin (HOMA-AD) is the most sensitive predictor of insulin resistance in obese children. Ann. Endocrinol. 73(1), 26-33 (2012).
17. Cizmecioglu FM, Etiler N, Ergen A et al. Association of adiponectin, resistin and high sensitive CRP level with the metabolic syndrome in childhood and adolescence. Exp. Clin. Endocrinol. Diabetes. 117(10), 622-627 (2009).
18. Pyrzak B, Ruminska M, Popko K, Demkow U. Adiponectin as a biomarker of the metabolic syndrome in children and adolescents. Eur. J. Med. Res. 15(Suppl. 2), 147-151 (2010).
19. Kynde I, Heitmann BL, Bygbjerg IC, Andersen LB, Helge JW. Hypoadiponectinemia in overweight children contributes to a negative metabolic risk profile 6 years later. Metab. Clin. Exp. 58(12), 1817-1824 (2009).
20. Aeberli I, Biebinger R, Lehmann R, L'allemand D, Spinas GA, Zimmermann MB. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J. Clin. Endocrinol. Metab. 92(11), 4359-4365 (2007).
21. Yeste D, Vendrell J, Tomasini R et al. Retinol-binding protein 4 levels in obese children and adolescents with glucose intolerance. Horm. Res. Paediatr. 73(5), 335-340 (2010).
22. Reinehr T, Stoffel-Wagner B, Roth CL. Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss. J. Clin. Endocrinol. Metab. 93(6), 2287-2293 (2008).
23. Kanaka-Gantenbein C, Margeli A, Pervanidou P et al. Retinol-binding protein 4 and lipocalin-2 in childhood and adolescent obesity: when children are not just "small adults". Clin. Chem. 54(7), 1176-1182 (2008).
24. Rhie YJ, Choi BM, Eun SH, Son CS, Park SH, Lee KH. Association of serum retinol binding protein 4 with adiposity and pubertal development in Korean children and adolescents. J. Korean Med. Sci. 26(6), 797-802 (2011).
25. Lee DC, Lee JW, Im JA. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metab. Clin. Exp. 56(3), 327-331 (2007).
26. Balagopal P, Graham TE, Kahn BB, Altomare A, Funanage V, George D. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J. Clin. Endocrinol. Metab. 92(5), 1971-1974 (2007).
27. Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-b selectively impair insulin action on glucose production. J. Clin. Invest. 111(2), 225-230 (2003).
28. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111(7), 932-939 (2005).
29. Utzschneider KM, Carr DB, Tong J et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 48(11), 2330-2333 (2005).
30. Iqbal N, Seshadri P, Stern L et al. Serum resistin is not associated with obesity or insulin resistance in humans. Eur. Rev. Med. Pharmacol. Sci. 9(3), 161-165 (2005).
31. Li M, Fisette A, Zhao XY, Deng JY, Mi J, Cianflone K. Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents. Int. J. Obes. (Lond.). 33(4), 424-439 (2009).